Maxcyte Share Discussion Threads

[thetrotsky] 30/8/2021 12:13

I see that the pre-market quote on NASDAQ is currently USD16.80, up USD1 on Friday's close; looking promising

[thetrotsky] 30/8/2021 12:05

With a range of USD18-36, there could be some furtehr intersting action on NASDAQ today; fingers crossed

[thetrotsky] 30/8/2021 12:03

I like USD36 ;-)

[acuere] 29/8/2021 19:47

Here is a summary of the broker ratings that appeared on 24th Aug.

William Blair Outperform
Stephens & Co. Overweight USD 19
BTIG Research Buy USD 22
Stifel Nicolaus Buy USD 18
Cowen Outperform
Wedbush Outperform USD 36.

[thetrotsky] 28/8/2021 09:19

Closed up over 12% in the US overnight at $15.80 (equivalent to ~£11.45). It will be interesting to see what the share price does on Monday (not a bank holiday in the US).

[charliec51] 25/8/2021 13:44

Thank you Pob, very useful. I also like this from the same note - lock in with clients is a big plus imv:

"Since MaxCyte’s technology is formally included in regulatory filings, we see little risk of SPL customers moving away from the company after entering the clinic."

[pob69] 25/8/2021 08:27

More from broker William Blair

"...make investing in the company a one-of-a-kind opportunity in life sciences"

[pob69] 24/8/2021 11:14

Seems like lots of new broker coverage detailed on twitter (sources not verified)

2 brokers involved in the US IPO
MaxCyte initiated with an Outperform at Cowen (TP not mentioned)
Maxcyte Initiation (Stifel) with a $18 TP

Addiytionally
BTIG analyst Mark Massaro initiates coverage on MaxCyte Inc. (NASDAQ: MXCT) with a Buy rating and a price target of $22.00.

[pob69] 13/8/2021 08:39

Partner Allogene updates market on ALLO-715

[multibagger] 11/8/2021 11:51

Thanks for sharing pob69 !

Interestingly the same Richard Penny /Crux Asset Management holds 3.11% of CYAN having taken part in the recent funding round.

DoI: CYAN is another of my big investments.

[pob69] 11/8/2021 11:43

Interesting comment from Richard Penny of Crux Asset Management in the telegraph (behind paywall)

"...I understand that MaxCyte is very happy that there is a strong balance between the existing specialist healthcare investors and some newer institutions. We retain a position in the stock. I would expect the company to accelerate growth and make incremental acquisitions with the proceeds. There is a positive outlook for the next 18 months."

[thetrotsky] 10/8/2021 16:28

There does appear to be an arbitrage opportunity between the UK and US markets at the moment. I wouldn't be too surprised to see the US market start to recover after the UK market closes. We may even see the US share price retesting the previous day's close. Just a hunch.

[nimbo1] 10/8/2021 11:30

From memory I think they more as part of nasdaq ipo if one reads the small print

[apad] 10/8/2021 10:40

Interesting grant of options today.

Looks fair(ish).

apad

[trident5] 10/8/2021 08:48

Does that mean the Yanks are not in for the long run?

[adamb1978] 09/8/2021 22:34

Should hopefully ensure a nice bounce in the morning.

Volumes seem to be moving to the US from what I see?

[nimbo1] 09/8/2021 21:23

Ridiculous discount - £12 close in US

[assagai] 09/8/2021 09:13

As we are currently at a discount of appr £1 to the US close price I would expect a forward move as they absorb today's licence news.

Ho Hum, so there is still a disconnect..

[adamb1978] 09/8/2021 08:36

Another licensee win....keep em' coming!

[assagai] 09/8/2021 07:28

And very nicely up today it would seem!

[nimbo1] 06/8/2021 20:31

nicely up on nasdaq

[adamb1978] 05/8/2021 09:57

Its worth watching the volumes - just over 10% from memory of the share capital was listed in the US. Last 3m average daily volume in the UK is just over 150k shares and so far its 63k shares in the US. I imagine that US figure settle down but would be good to see it gradually grind higher

[trident5] 05/8/2021 09:57

Apad - the pattern is - they're both falling. You're welcome.

[thetrotsky] 05/8/2021 09:47

Apad, I wish I could. I appreciate that it's early days yet, but I'm just beginning to get the feeling that it's the UK market that is dictating MXCT's share price at the moment which was not what we were expecting/hoping. Thus far the US market has consistently opened below its previous day's closing price and followed the UK market down. Not sure whether the additional US shares given to the MMs have helped. We are, at least, still above the listing price but I'd rather hoped that we'd be trading towards the top of the $15-$20 price range. As it is, we finished just above $15 last night and, if this morning's UK market is anything to go by, look set to open in the $14s this afternoon.

[apad] 05/8/2021 08:50

The Trotsky, let us know if you spot a pattern between US & UK - I certainly can't!

apad